Proteinase-activated receptors in the nervous system

Nature Reviews Neuroscience

Volumn 4, Issue 12, 2003, Pages 981-990

  Noorbakhsh, Farshid ^a,b   Vergnolle, Nathalie ^a   Hollenberg, Morley D ^a   Power, Christopher ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; CELL PROLIFERATION; CELL STRUCTURE; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DEMENTIA; ENCEPHALITIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIPLE SCLEROSIS; NERVOUS SYSTEM; ONTOGENY; PAIN; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; STROKE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0345724732     PISSN: 1471003X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrn1255     Document Type: Review

References (117)

1. Smith, A. I. & Funder, J. W. Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr. Rev. 9, 159-179 (1988).
2. Hollenberg, M. D. & Compton, S. J. International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol. Rev. 54, 203-217 (2002).
3. Vu, T. K., Hung, D. T., Wheaton, V. I. & Coughlin, S. R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068 (1991). Cloning of the first member of the PAR family, showing its activation by thrombin and by a peptide resembling the N terminus generated by thrombin.
4. Riewald, M. & Ruf, W. Proteinase-activated receptor activation by coagulation proteinases. Drug Dev. Res. 59, 400-407 (2003).
5. Ishihara, H. et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386, 502-506 (1997).
6. Xu, W. F. et al. Cloning and characterization of human protease-activated receptor 4. Proc. Natl Acad. Sci. USA 95, 6642-6646 (1998).
7. Nystedt, S., Emilsson, K., Wahlestedt, C. & Sundelin, J. Molecular cloning of a potential proteinase activated receptor. Proc. Natl Acad. Sci. USA 91, 9208-9212 (1994).
8. Nystedt, S., Larsson, A. K., Aberg, H. & Sundelin, J. The mouse proteinase-activated receptor-2 cDNA and gene. Molecular cloning and functional expression. J. Biol. Chem. 270, 5950-5955 (1995).
9. Molino, M. et al. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J. Biol. Chem. 272, 4043-4049 (1997).
10. Vu, T. K., Wheaton, V. I., Hung, D. T., Charo, I. & Coughlin, S. R. Domains specifying thrombin-receptor interaction. Nature 353, 674-677 (1991). Definition of PAR1 cleavage as the receptor-activating mechanism.
11. + exchange by a thrombin receptor antagonist. Biochem. Pharmacol. 49, 519-528 (1995).
12. Guyonnet Duperat, V., Jacquelin, B., Boisseau, P., Arveiler, B. & Nurden, A. T. Protease-activated receptor genes are clustered on 5q13. Blood 92, 25-31 (1998).
13. Dery, O., Corvera, C. U., Steinhoff, M. & Bunnett, N. W. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol. 274, C1429-C1452 (1998).
14. Rohatgi, T., Sedehizade, F., Sabel, B. A. & Reiser, G. Protease-activated receptor subtype expression in developing eye and adult retina of the rat after optic nerve crush. J. Neurosci. Res. 73, 246-254 (2003).
15. Nystedt, S., Emilsson, K., Larsson, A. K., Strombeck, B. & Sundelin, J. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur. J. Biochem. 232, 84-89 (1995).
16. Connolly, A. J., Ishihara, H., Kahn, M. L., Farese, R. V. Jr & Coughlin, S. R. Role of the thrombin receptor in development and evidence for a second receptor. Nature 381, 516-519 (1996).
17. Schmidt, V. A. et al. The human proteinase-activated receptor-3 (PAR-3) gene. Identification within a Par gene cluster and characterization in vascular endothelial cells and platelets. J. Biol. Chem. 273, 15061-15068 (1998).
18. Kahn, M. L. et al. A dual thrombin receptor system for platelet activation. Nature 394, 690-694 (1998).
19. Nakanishi-Matsui, M. et al. PAR3 is a co-factor for PAR4 activation by thrombin. Nature 404, 609-613 (2000).
20. Kahn, M. L., Nakanishi-Matsui, M., Shapiro, M. J., Ishihara, H. & Coughlin, S. R. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J. Clin. Invest. 103, 879-887 (1999).
21. Riewald, M., Petrovan, R. J., Donner, A., Mueller, B. M. & Ruf, W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296, 1880-1882 (2002).
22. Bono, F. et al. Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2. Arterioscler. Thromb. Vasc. Biol. 20, E107-E112 (2000).
23. Takeuchi, T. et al. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J. Biol. Chem. 275, 26333-26342 (2000).
24. Macfarlane, S. R., Seatter, M. J., Kanke, T., Hunter, G. D. & Plevin, R. Proteinase-activated receptors. Pharmacol. Rev. 53, 245-282 (2001).
25. Coughlin, S. R. Thrombin signalling and protease-activated receptors. Nature 407, 258-264 (2000).
26. i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells. Neuroscience 86, 597-609 (1998).
27. Smith-Swintosky, V. L. et al. Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration. J. Neurochem. 69, 1890-1896 (1997).
28. Striggow, F. et al. Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur. J. Neurosci. 14, 595-608 (2001). Determination of the neuronal localization of the four PAR subtypes and their altered expression during ischaemia.
29. Wang, H., Ubl, J. J. & Reiser, G. Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia 37, 53-63 (2002). Demonstration of the expression of all four PARs on rodent astrocytes, as well as of some downstream proliferative effects of PAR activation on astrocytes.
30. Gill, J. S., Pitts, K., Rusnak, F. M., Owen, W. G. & Windebank, A. J. Thrombin induced inhibition of neurite outgrowth from dorsal root ganglion neurons. Brain Res. 797, 321-327 (1998).
31. Steinhoff, M. et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism Nature Med. 6, 151-158 (2000). This study showed the production of proinflammatory neuropeptides, calcitonin gene-related peptide and substance P on PAR2-expressing primary spinal afferent neurons, and their release on PAR2 activation.
32. Corvera, C. U. et al. Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2. J. Physiol. (Lond.) 517, 741-756 (1999).
33. Reed, D. E. et al. Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons. J. Physiol. (Lond.) 547, 531-542 (2003). Demonstration that the activation of Par2 on submucosal neurons by mast-cell tryptase led to neuronal depolarization and hyperexcitability.
34. Dihanich, M., Kaser, M., Reinhard, E. Cunningham, D. & Monard, D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6, 575-581 (1991).
35. Deschepper, C. F., Bigornia, V., Berens, M. E. & Lapointe, M. C. Production of thrombin and antithrombin III by brain and astroglial cell cultures. Brain Res. Mol. Brain Res. 11, 355-358 (1991).
36. Weinstein, J. R., Gold, S. J., Cunningham, D. D. & Gall, C. M. Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J. Neurosci. 15, 2906-2919 (1995).
37. Shikamoto, Y. & Morita, T. Expression of factor X in both the rat brain and cells of the central nervous system. FEBS Lett. 463, 387-389 (1999).
38. Stead, R. H. et al. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc. Natl Acad. Sci. USA 84, 2975-2979 (1987).
39. Thecharides, T. C. Mast cells: the immune gate to the brain. Life Sci 46, 607-617 (1990).
40. Sawada, K., Nishibori, M., Nakaya, N., Wang, Z. & Saeki, K. Purification and characterization of a trypsin-like serine proteinase from rat brain slices that degrades laminin and type IV collagen and stimulates protease-activated receptor-2. J. Neurochem. 74, 1731-1738 (2000).
41. Wiegand, U., Corbach, S., Minn, A., Kang, J. & Muller-Hill, B. Cloning of the cDNA encoding human brain trypsinogen and characterization of its product. Gene 136, 167-175 (1993).
42. Cavanaugh, K. P., Gurwitz, D., Cunningham, D. D. & Bradshaw, R. A. Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J. Neurochem. 54, 1736-1743 (1990).
43. Beecher, K. L., Andersen, T. T., Fenton, J. W. & Festoff, B. W. Thrombin receptor peptides induce shape change in neonatal murine astrocytes in culture. J. Neurosci. Res 37, 108-115 (1994).
44. Grabham, P. & Cunningham, D. D. Thrombin receptor activation stimulates astrocyte proliferation and reversal of stellation by distinct pathways: involvement of tyrosine phosphorylation. J. Neurochem. 64, 583-591 (1995).
45. 12-induced cytoskeletal responses. J. Biol. Chem. 274, 26815-26821 (1999).
46. Wang, H., Ubl, J. J., Stricker, R. & Reiser, G. Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways Am. J. Physiol. Cell. Physiol. 283, C1351-C1364 (2002). Demonstration of the involvement of the extracellular signal-regulated kinase and PLC pathways in thrombin-induced astrocytic proliferation.
47. 2+-sensitive tyrosine kinase Pyk2 and Src in thrombin signalling in rat astrocytes. J. Neurochem. 84, 1349-1357 (2003).
48. Ehrenreich, H. et al. Thrombin is a regulator of astrocytic endothelin-1 Brain Res. 600, 201-207 (1993).
49. Neveu, I., Jehan, F., Jandrot-Perrus, M., Wion, D. & Brachet, P. Enhancement of the synthesis and secretion of nerve growth factor in primary cultures of glial cells by proteases: a possible involvement of thrombin. J. Neurochem. 60, 858-867 (1993).
50. Debeir, T., Gueugnon, J., Vige, X. & Benavides, J. Transduction mechanisms involved in thrombin receptor-induced nerve growth factor secretion and cell division in primary cultures of astrocytes. J. Neurochem. 66, 2320-2328 (1996).
51. Miller, S., Sehati, N., Romano, C. & Cotman, C. W. Exposure of astrocytes to thrombin reduces levels of the metabotropic glutamate receptor mGluR5. J. Neurochem. 67, 1435-1447 (1996).
52. Pechan, P. A., Chowdhury, K., Gerdes, W. & Seifert, W. Glutamate induces the growth factors NGF, bFGE the receptor FGF-R1 and c-fos mRNA expression in rat astrocyte culture. Neurosci. Lett. 153, 111-114 (1993).
53. Nakahara, K., Okada, M. & Nakanishi, S. The metabotropic glutamate receptor mGluR5 induces calcium oscillations in cultured astrocytes via protein kinase C phosphorylation. J. Neurochem. 69, 1467-1475 (1997).
54. Ye, Z. C. & Sontheimer, H. Metabotropic glutamate receptor agonists reduce glutamate release from cultured astrocytes Glia 25, 270-281 (1999).
55. Gurwitz, D. & Cunningham, D. D. Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc. Natl Acad. Sci. USA 85, 3440-3444 (1988).
56. Gloor, S., Odink, K., Guenther, J., Nick, H. & Monard, D. A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins. Cell 47, 687-893 (1986).
57. Debeir, T., Benavides, J. & Vige, X. Involvement of protease-activated receptor-1 in the in vitro development of mesencephalic dopaminergic neurons. Neuroscience 82, 739-752 (1998).
58. Turgeon, V. L., Lloyd, E. D., Wang, S., Festoff, B. W. & Houenou, L. J. Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation. J. Neurosci. 18, 6882-6891 (1998).
59. Monard, D. Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth. Trends Neurosci. 11, 541-544 (1988).
60. Liu, Y., Fields, R. D., Festoff, B. W. & Nelson, P. G. Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction. Proc. Natl Acad. Sci. USA 91, 10300-10304 (1994).
61. Liu, Y., Fields, R. D., Fitzgerald, S., Festoff, B. W. & Nelson, P. G. Proteolytic activity, synapse elimination, and the Hebb synapse. J. Neurobiol. 25, 325-335 (1994).
62. Gingdch, M. B., Junge, C. E., Lyuboslavsky, P. & Traynelis, S. F. Potentiation of NMDA receptor function by the serine protease thrombin. J. Neurosci. 20, 4582-4595 (2000).
63. de Garavilla, L. et al. Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism. Br. J. Pharmacol. 133, 975-987 (2001).
64. Linden, D. R., Manning, B. P., Bunnett, N. W. & Mawe, G. M. Agonists of proteinase-activated receptor 2 excite guinea pig ileal myenteric neurons. Eur. J. Pharmacol. 431, 311-314 (2001).
65. Kirkup, A. J., Jiang, W., Bunnett, N. W. & Grundy, D. Stimulation of the proteinase-activated receptor 2 excites jejunal afferent nerves in anaesthetised rats. J. Physiol. 552, 589-601 (2003).
66. Gao, C. et al. Serine proteases excite myenteric neurons through protease-activated receptors in guinea pig small intestine. Gastroenterology 123, 1554-1564 (2002).
67. Asfaha, S., Brussee, V., Chapman, K., Zochodne, D. W. & Vergnolle, N. Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br. J. Pharmacol. 135, 1101-1106 (2002).
68. Vergnolle, N. et al. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nature Med. 7, 821-826 (2001). Demonstration of neurokinin-1-receptor-dependent and PAR2-induced thermal and mechanical hyperalgesia.
69. Hoogerwerf, W. A. et al. The proteinase-activated receptor 2 is involved in nociception. J. Neurosci. 21, 9036-9042 (2001).
70. Steinhoff, M. et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J. Neurosci. 23, 6176-6180 (2003).
71. Friedmann, I., Faber-Elman, A., Yoles, E. & Schwartz, M. Injury-induced gelatinase and thrombin-like activities in regenerating and nonregenerating nervous systems. FASEB J. 13, 533-543 (1999).
72. Niclou, S. P., Suidan, H. S., Pavlik, A., Vejsada, R. & Monard, D. Changes in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesion. Eur. J. Neurosci. 10, 1590-1607 (1998).
73. Green, B. T., Bunnett, N. W., Kulkarni-Narla, A., Steinhoff, M. & Brown, D. R. Intestinal type 2 proteinase-activated receptors: expression in opioid-sensitive secretomotor neural circuits that mediate epithelial ion transport. J. Pharmacol. Exp. Ther. 295, 410-416 (2000).
74. Kawabata, A. et al. The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. J. Clin. Invest 107, 1443-1450 (2001).
75. McLean, P. G., Aston, D., Sarkar, D. & Ahluwalia, A. Protease-activated receptor-2 activation causes EDHF-like coronary vasodilaton: selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors, and C-fibers. Circ. Res. 90, 465-472 (2002).
76. 2+ homeostasis and sensitivity to glucose deprivation-induced injury J. Neurosci. 15, 5840-5850 (1995).
77. Festoff, B. W., Smirnova, I. V., Ma, J. & Citron, B. A. Thrombin, its receptor and protease nexin I, its potent serpin, in the nervous system. Semin. Thromb. Hemost. 22, 267-271 (1996).
78. Donovan, F. M., Pike, C. J., Cotman, C. W. & Cunningham, D. D. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J. Neurosci. 17, 5316-5326 (1997).
79. Vaughan, P. J., Pike, C. J., Cotman, C. W. & Cunningham, D. D. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J. Neurosci. 15, 5389-5401 (1995). This report showed that PAR1 activation could protect neurons and astrocytes from the deleterious effects of glucose/growth supplement deprivation or oxidative stress.
80. Stefanis, L., Burke, R. E. & Greene, L. A. Apoptosis in neurodegenerative disorders. Curr. Opin. Neurol. 10, 299-305 (1997).
81. Festoff, B. W. et al. Motor neuron cell death in wobbler mutant mice follows overexpression of the G-protein-coupled, protease-activated receptor for thrombin. Mol. Med. 6, 410-429 (2000).
82. Boven, L. A. et al. Up-regulation of proteinase-activated receptor 1 expression in astrocytes during HIV encephalitis. J. Immunol. 170, 2638-2646 (2003). Demonstration of the proinflammatory role of astrocytic PAR1 activation in HIV encephalitis.
83. Moller, T., Hanisch, U. K. & Ransom, B. R. Thrombin-induced activation of cultured rodent microglia J. Neurochem. 75, 1539-1547 (2000).
84. Suo, Z. et al. Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J. Neurochem. 80, 655-666 (2002).
85. Donovan, F. M. & Cunningham, D. D. Signaling pathways involved in thrombin-induced cell protection. J. Biol. Chem. 273, 12746-12752 (1998).
86. Striggow, F. et al. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc. Natl. Acad. Sci. USA 97, 2264-2269 (2000). Report of the neuroprotective/degenerative roles of the thrombin/PAR1 axis in ischaemia.
87. Xi, G., Keep, R. F., Hua, Y., Xiang, J. & Hoff, J. T. Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 30, 1247-1255 (1999).
88. Xi, G., Hua, Y., Keep, R. F., Duong, H. K. & Hoff, J. T. Activation of p44/42 mitogen activated protein kinases in thrombin-induced brain tolerance. Brain Res 895, 153-159 (2001).
89. Nishino, A. et al. Thrombin may contribute to the pathophysiology of central nervous system injury. J. Neurotrauma 10, 167-179 (1993).
90. Turgeon, V. L. & Houenou, L. J. The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous system. Brain Res. Brain Res. Rev. 25, 85-95 (1997).
91. Vaughan, P. J., Su, J., Cotman, C. W. & Cunningham, D. D. Protease nexin-1, a potent thrombin inhibitor, is reduced around cerebral blood vessels in Alzheimer's disease. Brain Res. 668, 160-170 (1994).
92. Pike, C. J., Vaughan, P. J., Cunningham, D. D. & Cotman, C. W. Thrombin attenuates neuronal cell death and modulates astrocyte reactivity induced by β-amyloid in vitro. J. Neurochem 66, 1374-1382 (1996).
93. Power, C. & Johnson, R. T. Neuroimmune and neurovirological aspects of human immunodeficiency virus infection. Adv. Virus Res. 56, 389-433 (2001).
94. Power, C., Gill, M. J. & Johnson, R. T. Progress in clinical neurosciences: the neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy. Can. J. Neurol. Sci. 29, 19-32 (2002).
95. Clements, G. J. et al. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Res. Hum. Retroviruses 7, 3-16 (1991).
96. Schulz, T. F. et al. Effect of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to proteolytic cleavage. AIDS Res. Hum. Retroviruses 9, 159-166 (1993).
97. Johnson, M. E., Lin, Z., Padmanabhan, K., Tulinsky, A. & Kahn, M. Conformational rearrangements required of the V3 loop of HIV-1 gp120 for proteolytic cleavage and infection. FEBS Lett. 337, 4-8 (1994).
98. - cells. AIDS Res. Hum. Retroviruses 11, 81-85 (1995).
99. Kido, H., Niwa, Y., Beppu, Y. & Towatari, T. Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, infuenza virus A and Sendai virus. Adv. Enzyme Regul. 36, 325-347 (1996).
100. Kido, H., Towatari, T., Niwa, Y., Okumura, Y. & Beppu, Y. Cellular proteases involved in the pathogenicity of human immunodeficiency and influenza viruses. Adv. Exp. Med. Biol. 389, 233-240 (1996).
101. Niwa, Y., Yano, M., Futaki, S., Okumura, Y. & Kido, H. T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120, Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120. Eur. J. Biochem. 237, 64-70 (1996).
102. Avril, L. E., Di Martino-Ferrer, M., Barin, F. & Gauthier, F. Interaction between a membrane-associated serine proteinase of U-937 monocytes and peptides from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) gp120 envelope glycoprotein. FEBS Lett. 317, 167-172 (1993).
103. Avril, L. E., Di Martino-Ferrer, M., Pignede, G., Seman, M. & Gauthier, F. Identification of the U-937 membrane-associated proteinase interacting with the V3 loop of HIV-1 gp120 as cathepsin G. FEBS Lett. 345, 81-86 (1994).
104. Avdl, L. E., di Martino-Ferrer, M., Brillard-Bourdet, M. & Gauthier, F. Inhibition of U-937 membrane-associated cathepsin G by GP120 (IIIB) and V3 loop-derived peptides from several strains of HIV-1. FEBS Lett. 367, 251-256 (1995).
105. Pal, R. et al. Characterization of a neutralizing monoclonal antibody to the external glycoprotein of HIV-1. Intervirology 34, 86-93 (1992).
106. Gu, R., Westervelt, P. & Ratner, L. Role of HIV-1 envelope V3 loop cleavage in cell tropism. AIDS Res. Hum. Retroviruses. 9, 1007-1015 (1993).
107. Xi, G., Reiser, G. & Keep, R. F. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J. Neurochem. 84, 3-9 (2003).
108. Raza, S. L., Nehring, L. C., Shapiro, S. D. & Cornelius, L. A. Proteinase-activated receptor-1 regulation of macrophage elastase (MMP-12) secretion by serine proteinases. J. Biol. Chem. 275, 41243-41250 (2000).
109. Power, C. et al. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann. Neurol. 53, 731-742 (2003).
110. Toms, R., Weiner H. L. & Johnson, D. Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. J. Neuroimmunol. 30, 169-177 (1990).
111. Ibrahim, M. Z., Reder, A. T., Lawand, R., Takash, W. & Sallouh-Khatib, S. The mast cells of the multiple sclerosis brain. J. Neuroimmunol. 70, 131-138 (1996).
112. Pedotti, R. et al. Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. Proc. Natl Acad. Sci. USA 100, 1867-1872 (2003).
113. Lock, C. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nature Med. 8, 500-508 (2002).
114. Rozniecki, J. J., Hauser, S. L., Stein, M., Lincoln, R. & Theoharides, T. C. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37, 63-66 (1995).
115. Hollenberg, M. D., Saifeddine, M. & Zwiers, H. Proteinase-activated receptors (PARs): activation of PAR1 and PAR2 by a proteolytic fragment of the neuronal growth associated protein B-50/GAP-43. Can. J. Physiol. Pharmacol. 78, 81-85 (2000).
116. Jalink, K. et al. Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho. J. Cell. Biol. 126, 801-810 (1994).
117. Ellis, C. A. et al. Thrombin induces proteinase-activated receptor-1 gene expression in endothelial cells via activation of Gi-linked Ras/mitogen-activated protein kinase pathway J. Biol. Chem. 274, 13718-13727 (1999).